Skip to main content
Log in

Evidence for pneumococcal vax in developing countries compelling

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA.Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet 369: 389-396, No. 9559, 3 Feb 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evidence for pneumococcal vax in developing countries compelling. Pharmacoecon. Outcomes News 522, 5 (2007). https://doi.org/10.2165/00151234-200705220-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705220-00012

Keywords

Navigation